We recently resumed reading journalistic notes that refer to irregularities during the RNA vaccine research and development process carried out by Pfizer laboratories. This is not the first time we hear about this kind of news.
On November 2, 2021, an article was published in the British Medical Journal BMJ, in which regional director Brooke Jackson who worked for “Ventabia“A laboratory subcontracted by Pfizer to prepare groups that received a placebo or the COVID-19 vaccine incurred omissions, errors, falsification of documents and other irregular behavior which, even when reported to the FDA, were not investigated with the rigor with which Others laboratories that did not even have WHO recognition became necessary for even smaller failures than the one reported by Jackson.
In the fall of 2020, Pfizer CEO Albert Bourla publishes a letter assuring them that they will develop a vaccine that will end the COVID 19 pandemic.
Bourla assured that the vaccine “would be authorized in the United States”.
Researchers involved in the vaccine research and development process have argued that accelerating the process could have a cost in terms of the safety of people and the integrity of the information collected.
The research team hired by Pfizer Ventabia Research Ggroup through its regional director stated that the company:
- You falsified your relationship information
- He did not respect the double-blind status
- Untrained personnel used
- It responded slowly to reports of adverse effects during phase three
- Quality control personnel were overwhelmed by the number of incidents and reports received.
Brooke Jackson, the regional director, has repeatedly reported these issues and received no response and notified the FDA. The next day she was fired Salebi.
It is very likely that these reports and eventualities will not have a significant impact on the efficacy of the vaccine, but in themselves they are ethical faults that violate clinical research and development discipline and procedures. The observation of asymmetric evaluation and sanction processes for laboratories does not escape our attention and unfortunately reflects interests that go beyond the well-being of patients and certainly involve economic and also geopolitical interests. It is amazing how people defend “Western” vaccines just for being Western vaccines. Because if Chinese or Russian or Cuban vaccines exhibit this type of irregularity, they would demand severe sanctions against those laboratories, including the health systems of those nations.
It is very important that when we establish a scientific judgment we do so with the rigor of knowledge and with an ethics without prejudice of any kind. Contaminating the scientific discourse on vaccines by the scientific community opens a window of opportunity for misinformed and malicious people who will always have an anti-vaccine message and which will impact the population, as we have already seen, and some people will decide not to get vaccinated. just because the vaccine offered by health systems “isn’t that good”
This pandemic has had many phases and in each of them there have been prominent scientists who have made comments, interviews and observations on social networks, media of incalculable scientific and social value. Other comments and opinions have been biased, sponsored and directed at groups or individuals, these views have not withstood the test of time.
It is very important that when we issue an opinion we take into account the impact it will have on the population both to convey certainty, reliable information and we know that this will usually cause a change in people’s behavior and we cannot ignore our level of responsibility when we issue a comment that others listen to.
Reference
Thacker, PD (2021). Covid-19: the researcher denounces the data integrity problems in the Pfizer vaccine trial. bmj, 375.
Hector L. Frisbie
He was born in Mexico City in 1965. He graduated in Surgeon in 1989 in Mexico City. From the specialty of Gynecology and Obstetrics in 1996 in Mexico City. He is a fellow of the American College of Obstetrics and Gynecology. He graduated in Senior Management in Public Health Institutions from IPADE. Head of the Gynecology and Obstetrics Service at the Dalinde Medical Center in Mexico City. General Director of the Hospital of High Specialties Maternal and Infantile of León, Guanajuato. He is a candidate for a doctorate in public health from Walden University in Minneapolis, Minnesota. Since 2010 he has practiced medicine in the United States. He regularly participates in health interviews on the UNIVISION and TELEMUNDO networks. He has an educational channel on YouTube on health aspects associated with a newscast and it airs every week in the Mexican Republic.
